167 related articles for article (PubMed ID: 1543536)
1. Insensitivity of the chick embryo müllerian duct to human recombinant müllerian-inhibiting substance.
Weniger JP; Cate RL; Zeis A
J Mol Endocrinol; 1992 Feb; 8(1):73-7. PubMed ID: 1543536
[TBL] [Abstract][Full Text] [Related]
2. Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat.
Tsuji M; Shima H; Yonemura CY; Brody J; Donahoe PK; Cunha GR
Endocrinology; 1992 Sep; 131(3):1481-8. PubMed ID: 1505479
[TBL] [Abstract][Full Text] [Related]
3. [Antagonistic actions of testosterone and the anti-mullerian hormone on the mullerian duct of the chick embryo in culture in vitro].
Weniger JP; Zeis A
Arch Anat Microsc Morphol Exp; 1982; 71(2):99-106. PubMed ID: 6897160
[TBL] [Abstract][Full Text] [Related]
4. Quantitative change in fibronectin in cultured müllerian mesenchymal cells in response to diethylstilbestrol and müllerian-inhibiting substance.
Teng CS
Dev Biol; 1990 Jul; 140(1):1-7. PubMed ID: 2358110
[TBL] [Abstract][Full Text] [Related]
5. Estrogen inhibition of Mullerian inhibiting substance in the chick embryo.
Hutson JM; Ikawa H; Donahoe PK
J Pediatr Surg; 1982 Dec; 17(6):953-9. PubMed ID: 6897657
[TBL] [Abstract][Full Text] [Related]
6. Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain.
MacLaughlin DT; Hudson PL; Graciano AL; Kenneally MK; Ragin RC; Manganaro TF; Donahoe PK
Endocrinology; 1992 Jul; 131(1):291-6. PubMed ID: 1612008
[TBL] [Abstract][Full Text] [Related]
7. Müllerian inhibiting substance is present in embryonic testes of dogs with persistent müllerian duct syndrome.
Meyers-Wallen VN; Lee MM; Manganaro TF; Kuroda T; Maclaughlin D; Donahoe PK
Biol Reprod; 1993 Jun; 48(6):1410-8. PubMed ID: 8318594
[TBL] [Abstract][Full Text] [Related]
8. Steroid enhancement of Mullerian duct regression.
Ikawa H; Hutson JM; Budzik GP; MacLaughlin DT; Donahoe PK
J Pediatr Surg; 1982 Oct; 17(5):453-8. PubMed ID: 6897422
[TBL] [Abstract][Full Text] [Related]
9. The in vivo roles of müllerian-inhibiting substance.
Behringer RR
Curr Top Dev Biol; 1994; 29():171-87. PubMed ID: 7828438
[TBL] [Abstract][Full Text] [Related]
10. Müllerian inhibiting substance is present in testes of dogs with persistent müllerian duct syndrome.
Meyers-Wallen VN; Donahoe PK; Ueno S; Manganaro TF; Patterson DF
Biol Reprod; 1989 Nov; 41(5):881-8. PubMed ID: 2576223
[TBL] [Abstract][Full Text] [Related]
11. Mullerian inhibiting substance: a fetal hormone with surgical implications.
Hutson JM; Donahoe PK; Budzik GP
Aust N Z J Surg; 1985 Dec; 55(6):599-605. PubMed ID: 2870703
[TBL] [Abstract][Full Text] [Related]
12. Steroid modulation of Mullerian duct regression in the chick embryo.
Hutson JM; Donahoe PK; MacLaughlin DT
Gen Comp Endocrinol; 1985 Jan; 57(1):88-102. PubMed ID: 3838289
[TBL] [Abstract][Full Text] [Related]
13. Quantification of müllerian inhibiting substance in developing chick gonads by a competitive enzyme-linked immunosorbent assay.
Teng CS
Dev Biol; 1987 Sep; 123(1):255-63. PubMed ID: 3622932
[TBL] [Abstract][Full Text] [Related]
14. The ontogeny of Mullerian inhibiting substance in the gonads of the chicken.
Hutson J; Ikawa H; Donahoe PK
J Pediatr Surg; 1981 Dec; 16(6):822-7. PubMed ID: 6896069
[TBL] [Abstract][Full Text] [Related]
15. Cyclic adenosine 3',5'-monophosphate modulation of mullerian duct regression.
Ikawa H; Hutson JM; Budzik GP; Donahoe PK
Endocrinology; 1984 May; 114(5):1686-91. PubMed ID: 6201348
[TBL] [Abstract][Full Text] [Related]
16. Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily.
Wilson CA; di Clemente N; Ehrenfels C; Pepinsky RB; Josso N; Vigier B; Cate RL
Mol Endocrinol; 1993 Feb; 7(2):247-57. PubMed ID: 8469238
[TBL] [Abstract][Full Text] [Related]
17. Androgen stimulation of nucleotide pyrophosphatase during mullerian duct regression.
Fallat ME; Hutson JM; Budzik GP; Donahoe PK
Endocrinology; 1984 May; 114(5):1592-8. PubMed ID: 6143657
[TBL] [Abstract][Full Text] [Related]
18. Müllerian-inhibiting substance: an update.
Donahoe PK; Budzik GP; Trelstad R; Mudgett-Hunter M; Fuller A; Hutson JM; Ikawa H; Hayashi A; MacLaughlin D
Recent Prog Horm Res; 1982; 38():279-330. PubMed ID: 6896925
[No Abstract] [Full Text] [Related]
19. Paracrine-mediated apoptosis in reproductive tract development.
Roberts LM; Hirokawa Y; Nachtigal MW; Ingraham HA
Dev Biol; 1999 Apr; 208(1):110-22. PubMed ID: 10075845
[TBL] [Abstract][Full Text] [Related]
20. Müllerian inhibiting substance in sex-reversed dogs.
Meyers-Wallen VN; Donahoe PK; Manganaro T; Patterson DF
Biol Reprod; 1987 Nov; 37(4):1015-22. PubMed ID: 3689844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]